| Mr Fred D Taylor, RPH | |
|
201 S Summit St, Arkansas City, KS 67005-2846 | |
| (620) 442-3500 | |
| Not Available |
| Full Name | Mr Fred D Taylor |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 201 S Summit St, Arkansas City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1851458319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-09549 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Fred D Taylor, RPH 201 S Summit St, Arkansas City, KS 67005-2846 Ph: (620) 442-3500 | Mr Fred D Taylor, RPH 201 S Summit St, Arkansas City, KS 67005-2846 Ph: (620) 442-3500 |
News Archive
Ampio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, whose lead drugs treat inflammatory diseases, including osteoarthritis and complications of Diabetes Mellitus such as diabetic macular edema (and others) announced today that it's CRO has completed analysis of the primary end point in the Optina clinical trial for DME conducted at St Michael Diabetes Hospital in Toronto Canada.
Much of the research on Alzheimer's disease has focused on the amyloid beta protein, which clumps together into sticky fibrils that form deposits in the brains of people with the disease.
Paid sick leave is one of the most powerful tools for preventing the spread of COVID-19 and other infectious diseases and ensuring all workers can access treatment-;yet tens of millions of workers across the U.S. lack coverage.
In a PLoS Neglected Tropical Diseases editorial, Peter Hotez of the Sabin Vaccine Institute outlines the diplomatic benefits of fighting NTDs in developing countries. He discusses why the State Department and USAID should be involved and outlines how they could work to expand NTD control.
Adverse events, or side effects, have traditionally been viewed as an unavoidable consequence in the therapeutic treatment of cancer patients. Yet sufficient data exists to study the relationship between molecular mechanisms, and drug-induced phenotypes to learn about - and even predict - adverse events in patients.
› Verified 4 days ago
Erica Tackett, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2701 N Summit St, Arkansas City, KS 67005 Phone: 620-442-2051 | |
Koffi Kolagbe, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 425 N Summit St, Arkansas City, KS 67005 Phone: 620-442-7842 | |
Meagan Mason, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 N Summit St, Arkansas City, KS 67005 Phone: 620-441-0283 Fax: 620-441-0887 | |
Amber Dawn Moore, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 N Summit St, Arkansas City, KS 67005 Phone: 620-441-0283 Fax: 620-441-0887 | |
Karen Kay Pontius, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 201 S Summit St, Arkansas City, KS 67005 Phone: 620-442-3500 | |
Heather Lowrie, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 212 S Summit St, Arkansas City, KS 67005 Phone: 620-442-2300 Fax: 620-442-9498 | |
Megan Marie Mangrum, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 425 N Summit St, Arkansas City, KS 67005 Phone: 620-442-7842 |